August 1, 2018 - Do you use your smartphone, tablet, or laptop to look at recipes while you’re cooking? Did it ever occur to you that you could be exposing your food – and yourself -- to the bacteria that those personal electronic devices may harbor?
June 1, 2018 - Blackhead disease (histomoniasis) is an important poultry disease that affects turkeys, chickens, peafowl, and game birds such as partridges, pheasants, and quail. The disease is caused by Histomonas meleagridis, a protozoan that is transmitted to the bird by the parasite Heterakis gallinarum, a type of nematode, or roundworm.
May 3, 2018 - Scientific expertise and research are key foundations of the work conducted within FDA’s Foods and Veterinary Medicine (FVM) program. Human and animal food safety, animal health and nutritional science are primary drivers of FVM’s research efforts.
FDA has created a new web page that provides a central source of information for scientists and other stakeholders around the world interested in FVM’s research priorities, activities, reporting and tracking.
March 8, 2018 - Redbarn Pet Products, LLC of Long Beach, CA is expanding their voluntary recall initially issued on February 9th. The voluntary recall expanded to include all lots of product manufactured with raw material from a single supplier because it has the potential to be contaminated with Salmonella.
December 5, 2017 - The Kroger Company has recalled Comforts FOR BABY Purified Water with Fluoride Added 1 GAL (3.78 L) with sell by dates from 4/26/2018 to 10/10/2018, after receiving complaints about mold in the product. Testing by Kroger has identified the mold as Talaromyces penicillium. The water is sold in clear containers, but the mold may not be visible with the naked eye.
The FDA is issuing this consumer alert to reach parents and caregivers who may have bought the product, which is intended for infants.
December 5, 2017 - The U.S. Food and Drug Administration has recommended that Primus Pharmaceuticals, Scottsdale, Arizona, voluntarily recall Limbrel, a capsule marketed to “manage the metabolic processes associated with osteoarthritis.” The company has not yet acted to remove the product from the market. Although the product is marketed as a medical food, the preliminary determination of the FDA investigation is that Limbrel is an unapproved new drug. The agency does not have mandatory recall authority over drug products.